Abstract
This chapter provides an overview of the current status of molecular and imaging markers in lower-grade glioma (LGG; diffuse glioma WHO grade II) management. We first review molecular markers acknowledged under the recent World Health Organization (WHO) diagnostic criteria that have enabled prognostic stratification of gliomas into distinct molecular subtypes. A discussion of current imaging markers follows, including surrogate markers of histological tumour grade and molecular features, and characteristics that aid in early detection of malignant transformation (MT).
Author supplied keywords
Cite
CITATION STYLE
Morrison, M. A., & Waldman, A. D. (2019). Imaging Markers of Lower-Grade Diffuse Glioma. In Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches (pp. 139–159). Springer International Publishing. https://doi.org/10.1007/978-3-030-27359-0_9
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
